Pathogenesis of swine influenza virus (Thai isolates) in weanling pigs: an experimental trial
- Donruethai Sreta†1,
- Roongtham Kedkovid†1,
- Sophon Tuamsang†2,
- Pravina Kitikoon†1 and
- Roongroje Thanawongnuwech1Email author
© Sreta et al; licensee BioMed Central Ltd. 2009
Received: 03 March 2009
Accepted: 25 March 2009
Published: 25 March 2009
The objective of this study is to investigate the pathogenesis of swine influenza virus (SIV) subtype H1N1 and H3N2 (Thai isolates) in 22-day-old SPF pigs.
The study found that all pigs in the infected groups developed typical signs of flu-like symptoms on 1–4 days post- infection (dpi). The H1N1-infected pigs had greater lung lesion scores than those of the H3N2-infected pigs. Histopathological lesions related to swine influenza-induced lesions consisting of epithelial cells damage, airway plugging and peribronchial and perivascular mononuclear cell infiltration were present in both infected groups. Immunofluorescence and immunohistochemistry using nucleoprotein specific monoclonal antibodies revealed positive staining cells in lung sections of both infected groups at 2 and 4 dpi. Virus shedding was detected at 2 dpi from both infected groups as demonstrated by RT-PCR and virus isolation.
The results demonstrated that both SIV subtypes were able to induce flu-like symptoms and lung lesions in weanling pigs. However the severity of the diseases with regards to lung lesions both gross and microscopic lesions was greater in the H1N1-infected pigs. Based on phylogenetic analysis, haemagglutinin gene of subtype H1N1 from Thailand clustered with the classical H1 SIV sequences and neuraminidase gene clustered with virus of avian origin, whereas, both genes of H3N2 subtype clustered with H3N2 human-like SIV from the 1970s.
Swine influenza is an acute, highly contagious, respiratory disease caused by type A influenza virus infection. Currently, 16 haemagglutinin (HA) subtypes and 9 neuraminidase (NA) subtypes are identified. Three main subtypes currently circulating in the pig population are classical swine influenza virus (SIV) and reassortant viruses of H1N1, H3N2 and H1N2 . However, pigs can also be infected with other subtypes of influenza A viruses. Pig plays a substantially important role in the ecology of influenza A virus  since they can act as a 'mixing vessel'. When co-infections among human, avian or swine influenza viruses occur within a specific host, any new subtype can be produced by antigenic reassortment .
Normally, SIV infects the epithelial lining of the respiratory tract producing clinical signs consisting of cough, fever, lethargy and anorexia. SIV-associated gross lung lesions observed in pigs are characterized by multifocal well-demarcated purplish-red lesions in the cranioventral areas of lung lobes known as a checker-board lung. SIV-induced microscopic lesions consist of epithelial disruption and attenuation in the bronchioles with later found hyperplastic proliferation and bronchiolitis obliterans. Mild to moderate peribronchiolar and perivascular lymphocytic infiltration occurs at nearly all levels of the airways. Viral antigen can be detected in epithelial cells of airways by immunohistochemistry (IHC) staining .
In Thailand, H1N1 SIV was the first subtype isolated from pigs with an influenza-like symptom in 1990 . Currently, both H1N1 and H3N2 subtypes are commonly found among the pig population in the country according to serological studies and virus isolation . Subsequently, in 2005 a new subtype H1N2 was isolated from pigs in Saraburi province . Wang et al.  reported that the H1 HA antigen was more resistant to natural cleavage into its two subunits (HA1 and HA2 subunits) than H3 HA antigen. It is possible that H3 virus could easily bind to the specific receptors resulting in better ability to infect cells than H1 virus. Moreover, human H3N2 virus could induce higher antibody response than that of H1N1 virus as revealed by hemagglutination-inhibition (HI) titers . In addition, Van Reeth et al.  demonstrated that pigs infected with a European H3N2 virus induced higher HI titers compared to a European H1N1 virus.
In Thailand, pathogenesis of SIV subtype H1N1 and H3N2 infection in swine has never been studied. Since different subtypes of the influenza type A viruses isolated from pigs are found to cause different pathogenic levels in pigs, the objective of this study is to investigate the pathogenesis of SIV (Thai isolates) subtype H1N1 (A/swine/Thailand/HF6/05) and H3N2 (A/swine/Thailand/S1/05) in weanling SPF pigs. Genetic characterization of the HA gene of both studied viruses were also performed in this report.
All pigs in the SIV infected groups showed clinical respiratory signs such as nasal discharge, coughing, sneezing and conjunctivitis by 1–4 dpi with mean clinical scores from 1.5 to 2.0. However, there were no significant differences between the infected groups. The negative control group showed no clinical respiratory signs. All studied pigs had no fever (≤ 40°C).
Percentages of gross lung lesions and the presence of SIV-specific antigen based on immunohistochemistry (IHC) staining
Pig 1 (%)
Pig 1 (%)
Pig 2 (%)
Pig 1 (%)
Pig 2 (%)
Microscopic lung lesions in both infected groups showed a thin layer bronchiolar lining of attenuated epithelium. Subsequently, necrosis and sloughing off of the epithelial cells with loose lymphocytes infiltrating around the bronchiole was evident. The microscopic lung lesions were scored 2, 1 and 0 in both infected groups at 2, 4 and 12 dpi, respectively. The lungs of all control pigs had no microscopic lesion scores at any necropsied date.
There were no differences in the virus titers in both experimental SIV-infected groups. The virus titers at 2 dpi were between 102 – 103 TCID50/ml either from lung tissues or from bronchoalveolar lavage fluid (BALF) in both infected groups. There was no virus titre at 4 or 12 dpi neither from lung nor from BALF in both infected groups or in the control pigs at any necropsied date (data not shown).
RT-PCR using specific primers for the matrix protein gene to confirm the presence of SIV in the nasal swabs revealed positive results only between 2–4 dpi in the H1N1-infected group and only at 2 dpi in the H3N2-infected group. SIV genetic material was not found in the nasal swabs or the sera of the negative control pigs.
Haemagglutination-inhibition (HI) assay
Sera from pigs in the control group had no antibody titres (≤ 1:10 HI titre) to either H1N1 or H3N2 subtypes at all collected dates. Sera from pigs in the H3N2-infected group had no antibody titres (≤ 1:10 HI titre) to the H1N1 subtype. Similarly, sera from pigs in the H1N1-infected group had no antibody titres (≤ 1:10 HI titre) to the H3N2 subtype. H3N2-infected pigs had 1:40 HI titre at 4 and 12 dpi to the H3N2 subtype. Interestingly, H1N1-infected group had the HI titre (1:160 HI titre) to the H1N1 subtype at 12 dpi.
Pathogenic bacterial culture and identification
Pathogenic bacterial culture yielded negative results from the tracheal swabs and lung tissues in all groups at 2, 4 and 12 dpi. In addition, Mycoplasma hyopneumoniae were not found by PCR tested from lung tissues in all pigs.
DNA Sequencing and Phylogenetic analysis
Subtype and homology analysis of HA and NA genes of the H1N1 and H3N2 challenge viruses
Virus with homology of HA gene
Virus with homology of NA gene
A/swine/Cotes d'Armor/1488/99 (H1N1)
A/swine/Nakhon pathom/NIAH586-1/05 (H3N2)
A/swine/Nakhon pathom/NIAH586-1/05 (H3N2)
A/swine/Nakhon pathom/NIAH586-2/05 (H3N2)
A/swine/Nakhon pathom/NIAH586-2/05 (H3N2)
The results demonstrated that both SIV subtypes (Thai isolates) were able to induce the flu-like symptoms and lesions compatible with viral pneumonia in the cranioventral areas and were able to cause broncho-interstitial pneumonia similar to previous reports [4, 10–12]. The pig lung is certainly the major site of swine influenza virus replication  since we did not find any viraemic pig or SIV antigen detection outside the lung tissue at any day of infection. IHC and RT-PCR seemed to be more sensitive than the virus isolation. The course of infection was limited to less than a week in both SIV-infected groups as SIV antigen detection was found positive only at 2–4 dpi. The SIV antigen was found in the nuclei of the bronchial and bronchiolar epithelial cells, pneumocytes and pulmonary macrophages with similar levels in both SIV-infected groups indicating no differences between the two subtypes in the viral protein production or replication. It should be noted that both studied Thai isolates of both subtypes replicated only in the respiratory tract of pigs and shed the virus in the nasal secretions similar to other SIV. The clinical respiratory signs and lung pathology in swine influenza-infected pigs are commonly induced by the pro-inflammatory cytokines such as IFN-α, TNF-α, IL-1 α and β, and IL-6 in bronchoalveolar lavage fluids and the amount of viral load in the lung tissue . Our results showed that pigs in both SIV-infected groups showed more severe clinical respiratory signs and had higher body temperature compared to the control pigs. Although, none of the studied pigs had fever, pigs in both SIV-infected groups had slight elevated body temperature. However, cytokines responsible for those clinical signs and lesions were not done in this study.
It is generally believed that there is no cross-protection between H1N1 and H3N2 viruses . The HI test between H1N1 and H3N2-infected groups had no cross HI antibody reaction in this study. Commonly, infection with H3N2 viruses induces higher HI titers than those of H1N1 infection [9, 14]. Wang et al.  found that the cleavage site of HA antigen of H3 virus (A/Panama/2007/99) was cleaved easier than that of H1 virus (A/New Caledonia/20/99) in transiently transfected 293T cells possibly making the H3 viruses more immunogenic. Similarly, a recombinant vaccine study in elderly humans using A/Panama/2007/99 (H3N2), A/New Caledonia/20/99 (H1N1) or influenza virus type B as virus sources showed that H3N2 virus induced significant higher HI titres than that of H1N1 virus . In contrast, the H1N1-infected pigs in this study induced higher HI titres than that of the H3N2-infected pigs at 12 dpi. Similarly, Kitikoon et al.  showed that HI titre of the H1N1-infected pigs at 7 dpi was higher than that of the H3N2-infected pigs. However, the HI titres at 14 and 21 dpi in the H3N2 virus-infected pigs were higher in that study. Different viruses used in the studies may yield different results due to the origin of those isolates. Interestingly, the antigenic site of the H1N1 used in this study contained the changed in the amino acid sequence of haemagglutinin which may result in increased immunogenicity and induced more severe clinical diseases. However, the antigenic site of the H3N2 virus used in this study had no amino acid changes. In addition, we did not have the HI results after 12 dpi in our study.
Recently, genetic analysis of the HA gene of Thai SIV  showed that the recent Thai H1N1 virus belonged to the classical swine H1N1 lineage and had the highest homology to the human isolate A/Thailand/271/05(H1N1). The H3N2 subtype belonged to the human H3N2 lineage and showed highest homology to the H3N2 human influenza virus from the 1970s A/Bilthoven/2600/75(H3N2) . Similarly, in our study nucleotide sequences of both HA and NA genes of A/Thailand/HF6/05(H1N1) also belonged to the classical swine H1N1 lineage and A/Thailand/S1/05(H3N2) belonged to the human H3N2 lineage. Since those viruses were isolated from the same province and in the same year, geographic distribution could be an explanation for the similarity of those viruses.
Interestingly, both viruses in this study were isolated from the same farm in August 2005. We did not find any genetic shift in those viruses or any reassortant virus such as H1N2 subtype occurring in the farm (unpublished data). Whole genome sequencing of all 8 genes is needed to be evaluated in both viruses. It is possible that the new reassortant virus might occur in Thailand since both studied viruses were isolated from the same farm. However, our results showed that the Thai SIV subtypes, H1N1 and H3N2, are still circulating in the pig population in Thailand since the first report in 1990. Our studied viruses were able to induce flu-like lesions in weanling pigs. Surveillance and molecular investigation of SIV in the country should be done continuously to prevent the future emerging or re-emerging influenza A virus in pigs population.
The results of this study may assist in the prevention and control of SIV infection in Thailand, especially for H1N1 and H3N2 subtypes. Based on the percentages of cranioventral pneumonic lesion and times of virus shedding, the H1N1 virus might play a major role in respiratory diseases in weanling pigs in that farm. More works are needed in the co-infection model with other respiratory pathogens and in the prevention and control of the SIV-related diseases in Thailand. In this study, investigations on virus transmissibility between sentinel animals housing together with infected animals were not performed. Therefore, whether these Thai H1N1 and H3N2 subtypes will be transmitted efficiently in the field situation requires further experimental and epidemiologic studies.
Swine influenza virus subtype H1N1 (A/swine/Thailand/HF6/05) and H3N2 (A/swine/Thailand/S1/05) were isolated from weanling pigs with respiratory signs in the same farm in Chonburi province in 2005. The viruses were propagated in embryonated chicken eggs for 3 passages and the virus concentration (107 TCID50/ml) was evaluated in Madin-Darby canine kidney (MDCK) cells and stored at -80°C until used.
Experimental DesignAnimal usage and handling protocols were approved by Chulalongkorn University-Faculty of Veterinary Science Animal Care and Use Committee (protocol No. 55/2549). The animals were housed at the BSL2 animal facility of the National Institute of Animal Health, Bangkok, Thailand throughout the experiment. Fifteen 22-day-old crossbred SPF pigs serologically negative for porcine reproductive and respiratory syndrome virus (PRRSV), Pseudorabies virus (PRV), Mycoplasma hyopneumoniae and SIV were obtained from a commercial farm and assigned to 3 different groups. The infected groups contained six pigs each and were intratracheally inoculated with H1N1 and H3N2 viruses (5 ml of 107 TCID50/ml) in group 1 and 2, respectively. Group 3 served as a negative control group containing three pigs which were mockedly infected with 5 ml of media (minimal essential medium (MEM)). Two pigs from the infected groups and one pig from the control group were necropsied at 2, 4 and 12 days post-infection (dpi). Nasal swabs were collected at 0, 1, 2, 3, 4, 5, 7, 10 and 12 dpi. Following collection, nasal swabs were immediately placed in the infected MEM with 5% BSA, 300 U/ml penicillin, 300 μg/ml streptomycin and 1–2 μg/ml trypsin) and stored at -80°C for evaluation of virus shedding. At each necropsy, sera were collected for assessing antibody response, bronchoalveolar lavage fluid (BALF) were collected for virus isolation and tissue samples from all organs were collected for microscopic lesion detection. In addition, tracheal swabs were tested for bacterial culture and identification.
Pigs were evaluated daily for respiratory disease symptoms including coughing, sneezing, tachypnea, dyspnea, nasal discharge and conjunctivitis. Pigs were observed and scored for the respiratory signs (ranged from 0 to 5) as previously described . Rectal temperature was also measured daily. Fever was recorded when the rectal temperature ≥ 40°C.
At necropsy, significant macroscopic lesions of all organs and percentage of lung lesions were recorded. Tissue samples from all lung lobes were collected and immediately identified for the presence of SIV-antigen by immunofluorescence assay (IFA) using anti-influenza A nucleoprotein monoclonal antibody (HB654404 B.V. EUROPEAN VETERINARY LABORATORY, the Netherlands).
Tissue samples from all organs were fixed in 10% neutral buffered-formalin, processed and embedded in paraffin as described previously . Sections were cut approximately 4–6 μm thick for histopathological and immunohistochemistry (IHC) tests using anti-influenza A nucleoprotein monoclonal antibody as previously described . Microscopic lesions were scored as previously described  and the scores were ranged from 0 to 3; 0 = normal bronchioles, 1 = mild bronchiolitis, 2 = moderate bronchiolitis, 3 = severe bronchiolitis.
SIV was isolated from nasal swabs, sera, BALF and lung tissues according to Kitikoon et al.  and the titres (TCID50/ml) were calculated according to Reed and Muench . Briefly, ten-fold serial dilutions of the nasal swab solution were inoculated onto MDCK cells and incubated until the cytopathic effect (CPE) was observed for at least 3 cell culture passages. Virus was identified by influenza A virus-specific staining. Prior to staining, cells were fixed with 4% phosphate-buffered formalin and washed with 0.5% Tween-20 in PBS (washing solution). Subsequently, the cells were incubated for 1 h with anti-influenza A nucleoprotein monoclonal antibody diluted 1:1,000 in the washing solution containing 1% BSA (diluting solution). After washing, the cells were incubated 1 h with the rabbit anti-mouse IgG conjugated horseradish peroxidase (Dako Cytomation, Carpinteria, California) diluted 1:400 with the diluting solution. The color was developed using a chromogen aminoethyl carbazole substrate (Sigma, St. Louis, Missouri). Each procedure contained mock-infected negative control cells and positive control cells infected with a known-titreed virus.
Sera and nasal swabs were performed to evaluate viraemia and virus shedding using M-gene specific RT-PCR as previously described . Viral RNAs were extracted using QIAamp Viral RNA Mini Kit (Qiagen, Valencia, CA) from 200 μl volume of each nasal swabs and sera. The RT-PCR was performed using Promega One step RT-PCR (Promega, USA) containing a specially formulated enzyme blend for both reverse transcription and PCR. The forward and reward primers were 5' TGA TCT TCT TGA AAA TTT GCA G 3'and 5' TGT TGA CAA AAT GAC CAT CG 3', respectively . The expected amplicon size is 276 bp. The RT-PCR was run at 94°C for 3 min for reverse transcription followed by 30 cycles of denaturing at 94°C for 30 s, annealing at 55°C for 30 s and extension at 72°C for 45 s and ended with a final extension step at 72°C for 7 min. The amplified PCR products were analyzed on a 1.5% agarose gel electrophoresis.
Haemagglutination-inhibition (HI) assay
Sera were evaluated for the HI antibody titres to both of the SIV subtypes, H1N1 and H3N2 using 0.5% chicken erythrocytes for haemagglutination. All sera were absorbed with Trypsin-Heat-Periodate to reduce nonspecific inhibitors before HI testing . Virus antigens utilized in the HI assays were the challenge viruses, H1N1 (A/swine/Thailand/HF6/05) and H3N2 (A/swine/Thailand/S1/05).
Full-length HA and NA genes of the studied subtype H1N1 and H3N2 were amplified using universal and specific primers [21, 22] with some modifications. The RT-PCR products were analyzed by 1% agarose gel electrophoresis, purified by NucleoSpin Extract II (Macherey-Nagel, Düren, Germany) and cloned into pGEMT Easy (Promega, Madison, WI, USA). Plasmids containing the viral genes were purified by NucleoSpin Plasmid (Macherey-Nagel, Düren, Germany) and sequenced by using synthetic oligonucleotides. Sequence data were edited and analyzed using Bioedit software. The phylogenetic trees were conducted in MEGA4  using neighbor-joining method with 1000 times bootstrapping replicates .
The authors would like to thank Drs. S. Kesdangsakonwut, T. Paphavasithi and R. Tantilertcharoen and Mr. S. Wangnaitham for their technical assistance and Dr. Sudarat Damrongwatanapokin, United States Agency for International Development (USAID)/Regional Development Mission-Asia for her kindness as an external examiner. This research was supported by The Rachadapiseksompoch Endowment Fund #R011_2550 and the National Research Council of Thailand #2551-231.
- Dee SA: Respiratory Disease of Pigs. In The Merck Veterinary Manual. 9th edition. Pensylvania: National Publishing Inc; 2005:1228.
- Easterday BC, Van Reeth K: Swine Influenza. In Desease of Swine; Iowa 8th edition. Edited by: Straw BE, Allaire SD, Mengeling WL, Taylor DJ Ames. 1999, 277-287.
- Webster R, Cox N, Stohi K: WHO Manual on Animal Influenza Diagnosis and Surveillance. World Health Organization; 2002:15-67.
- Thacker EL, Thacker BJ, Janke BH: Interaction between Mycoplasma hyopneumoniae and Swine Influenza Virus. J Clin Microbiol 2001, 39: 2525-2530. 10.1128/JCM.39.7.2525-2530.2001PubMed CentralView ArticlePubMed
- Kupradinun S, Peanpijit P, Bhodhikosoom C, Yoshioka Y, Endo A, Nerome K: The first isolation of swine H1N1 influenza viruses from pigs in Thailand. Arch Virol 1991, 118: 289-297. 10.1007/BF01314040View ArticlePubMed
- Damrongwatanapokin S, Pinychon W, Parchariyanon S, Damrongwatanapokin T: Serological study and isolation of influenza A virus infection of pigs in Thailand. Proceedings of the 19th IPVS Congress; 16–19 July 2006; Denmark 2006, 136.
- Wang S, Taaffe J, Parker C, Solorzano A, Cao H, Garcia-Sastre A, Lu S: Hemagglutinin (HA) Proteins from H1 and H3 Serotypes of Influenza A Viruses Require Different Antigen Designs for the Induction of Optimal Protective Antibody Responses as Studied by Codon-Optimized HA DNA Vaccines. J Virol 2006, 80: 11628-11637. 10.1128/JVI.01065-06PubMed CentralView ArticlePubMed
- Saurwein-Teissl M, Steger MM, Gluck R, Cryz S, Grubeck-Loebenstein B: Influenza vaccination in a healthy geriatric population: preferential induction of antibodies specific for the H3N2 influenza strain despite equal T cell responsiveness to all vaccine strains. Vaccine 1998, 16: 196-200. 10.1016/S0264-410X(97)88329-6View ArticlePubMed
- Van Reeth K, Gregory V, Hay A, Pensaert M: Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes. Vaccine 2003, 21: 1375-1381. 10.1016/S0264-410X(02)00688-6View ArticlePubMed
- Landolt GA, Karasin AI, Phillips L, Olsen CW: Comparison of the pathogenesis of two genetically different H3N2 influenza A viruses in pigs. J Clin Microbiol 2003, 41: 1936-1941. 10.1128/JCM.41.5.1936-1941.2003PubMed CentralView ArticlePubMed
- Jung K, Ha Y, Chae C: Pathogenesis of swine influenza virus subtype H1N2 infection in pigs. J Comp Pathol 2005, 132: 179-184. 10.1016/j.jcpa.2004.09.008View ArticlePubMed
- Kitikoon P, Nilubol D, Erickson BJ, Janke BH, Hoover TC, Sornsen SA, Thacker EL: The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination. Vet Immunol Immunopathol 2006, 112: 117-128. 10.1016/j.vetimm.2006.02.008View ArticlePubMed
- Van Reeth K: Cytokines in the pathogenesis of influenza. Vet Microbiol 2000, 74: 109-116. 10.1016/S0378-1135(00)00171-1View ArticlePubMed
- Kitikoon P, Strait EL, Thacker EL: The antibody responses to swine influenza virus (SIV) recombinant matrix 1 (rM1), matrix 2 (M2), and hemagglutinin (HA) proteins in pigs with different SIV exposure. Vet Microbiol 2008, 126: 51-62. 10.1016/j.vetmic.2007.07.009View ArticlePubMed
- Treanor JJ, Schiff GiM, Couch RB, Cate TR, Brady RC, Hay CM, Wolff M, She D, Cox MM: Dose-Related Safety and Immunogenicity of a Trivalent Baculovirus-Expressed Influenza-Virus Hemagglutinin Vaccine in Elderly Adults. J Infect Dis 2006, 193: 1223-1228. 10.1086/503050View ArticlePubMed
- Chutinimitkul S, Thippamom N, Damrongwatanapokin S, Payungporn S, Thanawongnuwech R, Amonsin A, Boonsuk P, Sreta D, Bunpong N, Tantilertcharoen R, et al.: Genetic characterization of H1N1, H1N2 and H3N2 swine influenza virus in Thailand. Arch Virol 2008, 153: 1049-1056. 10.1007/s00705-008-0097-7View ArticlePubMed
- Haines DM, Waters EH, Clark EG: Immunohistochemical detection of swine influenza A virus in formalin-fixed and paraffin-embedded tissues. Can J Vet Res 1993, 57: 33-36.PubMed CentralPubMed
- Richt JA, Lager KM, Janke BH, Woods RD, Webster RG, Webby RJ: Pathogenic and Antigenic Properties of Phylogenetically Distinct Reassortant H3N2 Swine Influenza Viruses Cocirculating in the United States. J Clin Microbiol 2003, 41: 3198-3205. 10.1128/JCM.41.7.3198-3205.2003PubMed CentralView ArticlePubMed
- Reed LJ, Muench H: A simple method of estimating fifty percent endpoints. Am J Hyg 1938, 27: 493-497.
- Payungporn S, Phakdeewirot P, Chutinimitkul S, Theamboonlers A, Keawcharoen J, Oraveerakul K, Amonsin A, Poovorawan Y: Single-step multiplex reverse transcription-polymerase chain reaction (RT-PCR) for influenza A virus subtype H5N1 detection. Viral Immunol 2004, 17: 588-593. 10.1089/vim.2004.17.588View ArticlePubMed
- Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR: Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 2001, 146: 2275-2289. 10.1007/s007050170002View ArticlePubMed
- Zou S: A practical approach to genetic screening for influenza virus variants. J Clin Microbiol 1997, 35: 2623-2627.PubMed CentralPubMed
- Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0. Mol Biol Evol 2007, 24: 1596-1599. 10.1093/molbev/msm092View ArticlePubMed
- Saitou N, Nei M: The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987, 4: 406-425.PubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.